The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Transcatheter Aortic Valve Implantation. Where are we?

EuroIntervention 2009;5:169-171.

1. Department of Cardiology, Erasmus MC Rotterdam, The Netherlands; 2. Department of Interventional Cardiology, Lenox Hill Heart and Vascular Institute of New York, New York, USA; 3. Department of Paediatric Cardiology, Great Ormond Street Hospital, Londo
Prospering from the know-how of percutaneous coronary angioplasty, coronary stents and the vast surgical experience with bioprosthetic valves, transcatheter aortic valve implantation (TAVI) – also called percutaneous aortic valve replacement or PAVR - has become a daily clinical reality. It was initially performed via the complex and hazardous antegrade transseptal approach in 2002, which has been replaced by the retrograde transfemoral or antegrade transapical technique1-4. In the beginning, the transfemoral approach required surgical access and/closure of the femoral artery, but became the first truly percutaneous technique of aortic valve replacement in 20065. In 2007 the CoreValve company and Edwards Lifesciences obtained CE ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Notes on clubs and the forming of group identity